StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
600257.SS$5.60+1.63%
Fair $5.60+0.0%

600257.SS

Dahu Health Industry Co., Ltd.

Consumer Defensive / Farm ProductsShanghai

$5.60

+0.09 (+1.63%)

Fairly Valued+0.0%Fair Value $5.60Fund rank 26/100 · Data gapFallback financials|
SA 32/D
F-Score: 7/9
Declining RevenueLow Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 26% · confianza 25%

FCF escenarios

weak_data · normalized FCF $142.9M · quality 45.0/100

Data gap 26/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 37/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

32/100

D

Piotroski

7/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 2unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. Revenue has declined for 2 consecutive years ROE is 0.6%, below the 5% threshold
Thesis & Journal · 600257.SSLocal privado en este navegador · Dahu Health Industry Co., Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$2.7B

P/E

560.0x

↑

EV/EBITDA

20.5x

↑

ROE

0.6%

↓

Gross Margin

27.6%

↑

Debt/Equity

0.86

↑
52-Week Range$6
$5$8

TradingView lightweight chart

600257.SS price, volumen y niveles de valoración

Último $5.600Periodo +80.8%
Fair value: $5.600

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-5.6%

FCF CAGR

+79.4%

FCF margin

22.6%

FCF / Net income

41.12x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $920.0M · net income $5.1M · FCF $208.3M

2022-FY → 2025-FY

Gross margin

27.6%+3.9% pts

Operating margin

9.1%+4.6% pts

Net margin

0.6%+7.1% pts

FCF margin

22.6%+19.3% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$920.0M$920.0M$1.04B$1.19B$1.09B
Net Income$5.1M$5.1M$-77.0M$-8.2M$-71.5M
EBITDA$156.5M$156.5M$76.4M$132.2M$47.9M
EPS0.010.01-0.16-0.02-0.15
Gross Margin27.6%27.6%23.1%24.5%23.7%
Operating Margin9.1%9.1%5.4%7.0%4.4%
Net Margin0.6%0.6%-7.4%-0.7%-6.5%
Balance Sheet
Debt/Equity0.860.860.920.990.99
Current Ratio2.282.28———
Cash Flow
Free Cash Flow$208.3M$208.3M$46.1M$142.9M$36.1M
Returns
ROE0.6%0.6%-9.7%-0.9%-8.1%
Valuation
P/E560.00560.00———
EV/EBITDA20.4820.4835.2123.5869.00
P/B3.533.532.692.953.03
Growth & Yield
Revenue Growth-11.9%-11.9%-12.5%9.0%—
EPS Growth106.3%106.3%-700.0%86.7%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

267.6%

muy exigente

EPS terminal req.

$0.50

Spread vs growth

-161.4%

5Y implied EPS CAGR

126.9%

muy exigente

EPS terminal req.

$0.60

Spread vs growth

-20.6%

10Y implied EPS CAGR

58.0%

muy exigente

EPS terminal req.

$0.97

Spread vs growth

48.3%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +12.4%

Total return

+12.4%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.16 → 0.01

Residual

+12.4%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+12.4%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.